References ABBOUD, R.T., JOHNSON, A.J.. RICHTER, A.M., ELWOOD, R.K. Comparison of in vitro neutrophil elastase release in nonsmokers and smokers. American Review of Respiratory Disease 128(3):507-510. 1983. AMERICAN CANCER SOCIETY. Unpublished tabulations. AMERICAN COLLEGE OF CHEST PHYSICIANS-AMERICAN THORACIC SOCIETY. Pulmonary terms and symbols. A report of the ACCP-ATS Joint Committee on Pulmonary Nomenclature. Chest 67(5):583-593, May 1975. AMERICAN THORACIC SOCIETY. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. American Review of Respiratory Disease 136(1):225-244, July 1987. ANDERSEN, P., CHRISTENSEN, K.M. Serum antibodies to pigeon antigens in smokers and nonsmokers. Acta Medica Scandinavica 213(3):191-193, 1983. ANDERSEN, P., PEDERSEN, D.F., BACH, B.. BONDE, G.J. Serum antibodies and immuno- globulins in smokers and nonsmokers. Clinical and Experimental Immunology 47(2):467- 473, February 1982. ANDERSEN, P., SCHONHEYDER, H. Antibodies to hen and duck antigens in poultry workers. Clinical Allergy 14(5):421-428, 1984. ANDERSON, H.R. Chronic lung disease in the Papua. New Guinea highlands. Thorax 34:647-653, 1979. ANDO, M., SUGIMOTO, M., NISHI, R., SUGA, M., HORIO. S.,. KOHROGI. H.. SHIMAZU, K., ARAKI, S. Surface morphology and function of human pulmonary alveolar macrophages from smokers and non-smokers. Thorax 39(11):850-856, 1984. ANTHONISEN, N.R. Lung Health Study. (Editorial.) American Review of Respiratory Disease 140(4):87 1-872. October 1989. ANTHONISEN, N.R., WRIGHT, E.C., HODGKIN, J.E.. IPPB TRIAL GROUP. Prognosis in chronic obstructive pulmonary disease. American Review of Respiratory Disease 133:14-20. 1986. ASHLEY, F.. KANNEL, W.B., SORLIE, P.D., MASSON, R. Pulmonary function: Relation to aging, cigarette habit, and mortality. The Framingham Study. Annals of Internal Medicine 82:739-745, 1975. BABBOTT, F.L. JR.. GUMP, D.W., SYLWESTER, D.L.. MACPHERSON, B.V., HOLLY, R.C. Respiratory symptoms and lung function in a sample of Vermont dairymen and industrial workers. American Journal of Public Health 70(3):24 1-245. 1980. BAHOUS, J., CARTIER. A.. PINEAU, L., BERNARD, C., GHEZZO, H.. MARTIN, R.R., MALO. J.L. Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult. Bulletin Européen de Physiopathologie Respiratoire 20(4):375— 380, July/August 1984. BAKE, B.. OXHOJ, H., SIXT. R., WILHELMSEN, L. Ventilatory lung function following two years of tobacco abstinence. Scandinavian Journal of Respiratory Diseases 58(6):311-318. December 1977. BALLAL. S.G. Cigarette smoking and respiratory symptoms among Sudanese doctors. East African Medical Journal 61(2):95—103, February 1984, BARTELIK. S., ZIOLO. H.. BARTELIK. M. Physiological and biochemical blood parameters in non-smokers and tobacco smokers. Polski Tvgodnik Lekarski 39(1):7-8. January 1984, BECK, G.J., DOYLE, C.A.. SCHACHTER, E.N. Smoking and lung function, Anrerican Review of Respiratory Disease 123(2):149-155, February 1981. BECK, G.J., DOYLE, C.A.. SCHACHTER, E.N. A longitudinal study of respiratory health in arural community. American Review of Respiratory Disease 125(4):375-381, April 1982. BECKLAKE, M.R.. PERMUTT, S. Evaluation of tests of lung function for “screening” for early detection of chronic obstructive lung disease. In: Macklem. P.T., Permutt, S. (eds.) The Lung in Transition Between Health and Disease. New York: Marcel Decker. 1979, pp. 345-387, BELL. D.Y.. HASEMAN. J.A., SPOCK. A.. MCLENNAN, G.. HOOK.G.E.R. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. American Review of Respiratory Disease 124:72-79, 1981. BEST. E.W.R. A Canadian Study of Smoking and Health. Department of National Health and Welfare, Epidemiology Division, Health Services Branch, Biostatistics Division, Research and Statistics Directorate. Ottawa, 1966, p. 137. BODE, F.R.. DOSMAN., J.. MARTIN, R.R.. MACKLEM. P.T. Reversibility of pulmonary function abnormalities in smokers. A prospective study of early diagnostic tests of small airways disease. American Journal of Medicine 5% t):43-52, July 1975. BOLIN, J.F., DAHMS, T.E.. SLAVIN, R.G. Effect of discontinuing smoking on Mecholy] sensitivity in asthmatic smokers. (Abstract.) Journal of Allergy and Clinical Immunology 64:207-208, 1980. BONINI,S. Smoking, IgE and occupational allergy. (Letter.) British Medical Journal 284:512- 513, February 13, 1982. BOSISIO, E., GRISETTI. G.C.. PANZUTI, F.. SERGI. M. Pulmonary diffusing capacity and its components (DM and VC) in young, healthy smokers. Respiration 40(6):307—3 10, 1980. BOSSE. R., SPARROW. D., GARVEY, A.J.. COSTA. P.T. JR.. WEISS. S.T., ROWE, J.W. Cigarette smoking, aging, and decline in pulmonary function: A longitudinal study. Archives of Environmental Health 35(4):247-252., July/August 1980. BOSSE, R.. SPARROW. D.. ROSE. C.L.. WEISS. S.T. Longitudinal effect of age and smoking cessation on pulmonary function. American Review of Respiratory Disease 123(4):378-38 1, 1981. BOYD. G.. MADKOUR, M.. MIDDLETON. S.. LYNCH. P. Effect of smoking on circulating antibody levels to avian protein in pigeon breeder's disease. Thorax 32:643-652, 1977. BRIDGES, R.B.. WYATT. R.J.. REHM. S.R. Effect of smoking on peripheral blood leukocytes and serum antiproteases. European Journal of Respiratory Diseases 66(Supplement 139):24— 33, 1985. BRODER. 1.. MINTZ, S.. HUTCHEON. M.. COREY. P.. SILVERMAN. F.,. DAVIES. G.. LEZNOFF, A.. PERESS, L.. THOMAS. P. Comparison of respiratory variables in grain ' elevator workers and civic outside workers of Thunder. Bay, Canada. American Review of Respiratory Disease 119(2):193-203, February 1979. BROWN. N.-E.. MCFADDEN., E.R. JR.. INGRAM. R.H. JR. Airway responses to inhaled histamine in asymptomatic smokers and nonsmokers. Journal of Applied Physiology 42(4): 508-513. April 1977. BUCZKO, G.B.. DAY, A.. VANDERDOELEN, J.L.. BOUCHER. R.. ZAMEL.N. Effects of cigarette smoking and short-term smoking cessation on airway responsiveness to inhaled methacholine. American Review of Respiratory Disease 129(1):12-14, January 1984. BUIST. A.S.. GHEZZO. H.. ANTHONISEN, N.R.. CHERNIACK, R.M.. DUCIC. S.. MACK- LEM. P.T., MANFREDA, J., MARTIN. R.R.. MCCARTHY, D., ROSS. B.B. Relationship between the single-breath N> test and age, sex, and smoking habit in three North American cities. American Review of Respiratory Disease 120(2):305-318, August 1979. , BUIST, A.S.. NAGY, J.M.. SEXTON. G.J. The effect of smoking cessation on pulmonary function: A 30-month follow-up of two smoking cessation clinics. American Review of Respiratory Disease 120(4): 953-957, Octaber 1979, BUIST, A.S.. SEXTON. G.J.. NAGY. J.M.. ROSS. B.B. The effect of smoking cessation and modification on lung function. Americun Review of Respiratory Disease 114C1):115~122, July 1976. ioe) wa) to BUIST, A.S.. VOLLMER. W.M. Prospective investigations in asthma, What have we learned from longitudinal studies about lung growth and senescence in asthma? Chest 91(Supple- ment):119S~126S, June 1987, BURNEY. P.G.J.. BRITTON. J.R.. CHINN. S.. TATTERSFIELD, A.E.. PAPACOSTA. A.O.. KELSON, M.C.. ANDERSON. F.. CORFIELD, D.R. Descriptive epidemiology of bronchial reactivity in an adult population: Results from a community study. Thoray 42(1):38-44. January 1987. BURROWS. B. An overview of obstructive lung diseases. Medical Clinics of North America 65(3):455-471, May 1981. BURROWS, B., HALONEN. M., BARBEE. R.A.. LEBOWITZ. M.D. The relationship of serum immunoglobulin E to cigarette smoking. American Review of Respiratory Disease 124 (5):523-525, November 1981. BURROWS. B.. HASAN, F.M., BARBEE. R.A.. HALONEN. M.. LEBOWITZ. M.D. Epidemiologic observations on eosinophilia and its relation to respiratory disorders. American Review of Respiratory Disease 122(5):709-719. November 1980. BURROWS, B., KNUDSON, R.J.. CAMILLI, A.E.. LYLE. S.K.. LEBOWITZ. M.D. The “horse-racing effect’ and predicting decline in forced expiratory volume in one second from screening spirometry. American Review of Respiratory Disease 135(4):788-793, April 1987. BURROWS. B.. KNUDSON, R.J.. CLINE. M.G., LEBOWITZ, M.D. Quantitative relation- ships between cigarette smoking and ventilatory function. American Review of Respiratory Disease 115(2):195-205, February (977. BURROWS. B.. LEBOWITZ, A.D.. BARBEE.R.A. Respiratory disorders and allergy skin-test reactions. Annals of Internal Medicine 84(2):134-139, February 1976. BURTON. R.C., FERGUSON, P.. GRAY. M.. HALL. J.. HAYES, M.. SMART. Y.C. Effects of age. gender, and cigarette smoking on human immunoregulatory T-cell subsets: Estab- lishment of normal ranges and comparison with patients with colorectal cancer and multiple sclerosis, Diagnostic Immunology 1(3):216-223, 1983. CAMILLI. A.E.. BURROWS, B., KNUDSON. R.J., LYLE, $.K.. LEBOWITZ, M.D. Longi- tudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. American Review of Respiratory Disease 135(4):794-799, April 1987. CAMNER, P., PHILIPSON. K.. ARVIDSSON, T. Withdrawal of cigarette smoking: A study on tracheobronchial clearance. Archives of Environmental Health 26:90-92, February 1973. CARSTENSEN, J.M., PERSHAGEN. G.. EKLUND, G. Montality in relation to cigarette and pipe smoking: 16 years’ observation of 25,000 Swedish men. Journal of Epidemiology and Conimunity Health 41:166-172, 1987. CASALE, T.B., RHODES, B.J.. DONNELLY, A.L., WEILER, JM. Airway responses to methacholine in asymptomatic nonatopic cigarette smokers. Journal of Applied Physiology 62(5):1888-1892, 1987. CENTERS FOR DISEASE CONTROL. Chronic disease reports: Chronic obstructive pul- monary disease mortality—United States. 1986. Morbidity and Mortality Weekly Report 38(32):549-552. August 18, 1989, CERVERI. I.. BRUSCHI.C..ZOIA. M.C., MACCARINI.L.. GRASSI. M.. LEBOWITZ. MD. RAMPULLA, C.. GRASSI C. Smoking habit and bronchial reactivity in normal subjects. A population-based study. American Review of Respiratory Disease 140:191—196, 1989. CHAN-YEUNG, M., VEDAL. S., KUS. J. MACLEAN, L.. ENARSON, D.. TSE. KS. Symptoms. pulmonary function, and bronchial hyperreactivity in western red cedar workers compared with those in office workers. American Review of Respiratory Disease 130:1038— 1041, 1984. COCKCROFT. D.W.. RUFFIN. R.E.. FRITH. P.A.. CARTIER. A.. JUNIPER. E.F.. DOLOVICH. J.. HARGREAVE. F.E. Determinants of allergen-induced asthma: Dose of allergen. circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. American Review of Respiratory Disease 120:1053-1058, 1979, COMSTOCK. G.W.. BROWNLOW. W.J., STONE. R.W.. SARTWELL. PE. Cigarette smok- ing and changes in respiratory findings. Archives of Environmental Health 21(1):50—57, July 1970, CORMIER, Y.. BELANGER. J. The fluctuant nature of precipitating antibodies in dairy farmers. Thorax 44:469-473, 1989. CORRE. F.. LELLOUCH. J.. SCHWARTZ. D. Smoking and leucocyte-counts. Results of an epidemiological survey. Lancet 2:632-634, September 18, 1971. COSIO, M., GHEZZO, H.. HOGG, J.C.. CORBIN. R.. LOVELAND. M.. DOSMAN. J. MACKLEM. P.T. The relations between structural changes in small airways and pulmonary- function tests. New England Journal of Medicine 298(23):1277—1281. June 8. 1977, DALES, L.G.. FRIEDMAN, G.D., SIEGELAUB. A.G.. SELTZER. C.C. Cigarette smoking and serum chemistry tests. Journal of Chronic Diseases 27(6):293—307. August 1974. DANIELE, R.P., DAUBER. J.H.. ALTOSE, M.D.. ROWLANDS, D.T. JR.. GORENBERG, D.J. Lymphocyte studies in asymptomatic cigarette smokers. A comparison between lung and peripheral blood. American Review of Respiratory Disease 116:997-1005, 1977. DAVIS, R.M.. NOVOTNY. T.E. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. American Review of Respiratory Disease 140(Sup- plement):S82-—S84, 1989. DEAN, G.. LEE. P.N.. TODD, G.F.. WICKEN, A.J.. SPARKS. D.N. Factors related to respiratory and cardiovascular symptoms in the United Kingdom. Journal of Epidemiology and Community Health 32(2):86-96, June 1978. DEMONCHY. J.G.R.. KAUFFMAN, H.F.. VENGE, P.. KOETER. G.H., JANSEN. H.M.. SLUITER. H.J., DE VRIES. K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. American Review of Respiratory Disease 131(3):373—376, March 1985. DESHAZO. R.D., BANKS, D.E.. DIEM, J.E.. NORDBERG. J.A.. BASER. Y., BEVIER. D.. SALVAGGIO. J.E. Bronchoalveolar lavage cell-lymphocyte interactions in normal non- smokers and smokers. Analysis with a novel system. American Review of Respiratory Disease 127:545-548, 1983. DIRKSEN. H.. JANZON. L.. LINDELL. S.E. Influence of smoking and cessation of smoking on lung function. A population study of closing volume and nitrogen wash-out. Scandinavian Journal of Respiratory Diseases 85( Supplement ):266—-274, 1974. DOCKERY, D.W.. SPEIZER. F.E., FERRIS, B.G. JR.. WARE, J.H.. LOUIS, T.A., SPIRO. A. If. Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. American Review of Respiratory Disease 137:286-292, 1988. DODGE, R.R.. BURROWS. B. The prevalence and incidence of asthma and asthma-like symptoms ina general population sample. American Review of Respiratory Disease 122:567- 575, 1980. DOLL. R.. GRAY, R.. HAFNER, B.. PETO. R. Mortality in relation to smoking: 22 years’ observations on female British doctors. British Medical Journal 280(6219):967-97 1. April 5, 1980. DOLL. R.. PETO. R. Mortality in retation to smoking: 20 years’ observations on male British doctors. British Medical Journal 2(605] ):1525-1536, December 25, 1976. DOPICO, G.A.. REDDAN, W.. TSIATIS. A.. PETERS. M.E.. RANKIN, J. Epidemiologic study of clinical and physiologic parameters in grain handlers of northern United States. American Review of Respiratory Disease 130:759-765, 1984. EBI-KRYSTON. K.L. Predicting 15 year chronic bronchitis mortality in the Whitehall study. Journal of Epidemiology und Community Health 43(2):168-172, June 1989. 354 EDELMAN, N.H., MITTMAN, C., NORRIS, A.H., COHEN. B.H., SHOCK, N.W. The effects of cigarette smoking upon spirometric performance of community dwelling men. American Review of Respiratory Disease 94(3):42 1-429, September 1966. ENARSON, D.A., CHAN-YEUNG, M., TABONA. M., KUS. J.. VEDAL. S.. LAM. S. Predictors of bronchial hyperexcitability in grainhandlers. Chest 87(4):452—-455, April 1985. ENJETI, S.. HAZELWOOD, B., PERMUTT. S.. MENKES. H.. TERRY, P. Pulmonary function in young smokers: Male—female differences. American Review of Respiratory Disease 118:667-676, 1978. FANTA, C.H., INGRAM, R.H. JR. Airway responsiveness and chronic airway obstruction. Medical Clinics of North America 65(3):473—487, May 1981. FEINLEIB, M., ROSENBERG, H.M., COLLINS, J.G., DELOZIER. J.E.. POKRAS, R.. CHEVARLEY, F.M. Trends in COPD morbidity and mortality in the United States. American Review of Respiratory Disease 140(Supplement):S9-S 18, 1989. FENNERTY, A.G., BANKS, J., EBDEN. P.. BEVAN, C. The effect of cigarette withdrawal on asthmatics who smoke. European Journal of Respiratory Diseases 71(5):395—399, November 1987. FERRIS, B.G. JR.. ANDERSON, D.O. The prevalence of chronic respiratory disease in a New Hampshire town. American Review of Respiratory Diseases 86:165—177, 1962. FERRIS, B.G. JR., HIGGINS, I.T.T., HIGGINS, M.W.. PETERS, J.M., VAN GANSE, W.F.. GOLDMAN, M.D. Chronic nonspecific respiratory disease, Berlin. New Hampshire, 1961- 1967: A cross-sectional study. American Review of Respiratory Disease |04(2):232-244, 1971. FERSON, M., EDWARDS, A., LIND, A., MILTON, G.W., HERSEY, P. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. /aternational Journal of Cancer 23:603-609, 1979. FINKLEA, J.F., HASSELBLAD, V., RIGGAN, W.B., NELSON, W.C., HAMMER, D.1.. NEWILL, V.A. Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization. American Review of Respiratory Disease 104(3):368— 376, September 1971. FINKLEA, J.F., SANDIFER, S.H., SMITH, D.D. Cigarette smoking and epidemic influenza. American Journal of Epidemiology 90(5):390-399, November 1969. FISHER, G.L., MCNEILL, K.L., FINCH, G.L., WILSON, F.D., GOLDE, D.W. Functional evaluation of lung macrophages from cigarette smokers and nonsmokers. Journal of the Reticuloendothelial Society 32(4):311-321, October 1982. FLETCHER, C., PETO, R. The natural history of chronic airflow obstruction. British Medical Journal 1(9):1645—1648, June 1, 1977. FLETCHER, C.M., ELMES, P.C., FAIRBAIRN, A.S., WOOD, C.H. The significance of respiratory symptoms and the diagnosis of chronic bronchitis ina working population. British Medical Journal 5147:258-266, August 29, 1959. FLETCHER, C.M., PETO, R., TINKER, C., SPEIZER. F.G. The Natural History of Chronic Bronchitis and Emphysema. An Eight-Year Study of E. arly Chronic Obstructive Lung Disease in Working Men in London. New York: Oxford University Press, 1976. FLETCHER, C.M., TINKER, C.M. Chronic bronchitis: A further study of simple diagnostic methods in a working population. British Medical Journal 5238: 1491-1498, May 27, 1961. FRANS, A., STANESCU, D.C.. VERITER, C., CLERBAUX, T.. BRASSEUR,. L. Smoking and pulmonary diffusing capacity. Scandinavian Journal of Respiratory Diseases 56(3):165— 183, September 1975. FRIEDMAN. G.D., SIEGELAUB, A.B. Changes after quitting cigarette smoking. Circulation 61(4):7 16-723, 1980. 355 FRIEDMAN, G.D.. SIEGELAUB, A.B., SELTZER, C.C., FELDMAN. R.. COLLEN, M.-F. Smoking habits and the leukocyte count. Archives of Environmental Health 26:137-143, March 1973. GADEK., J.E., FELLS, G.A.. CRYSTAL, R.G. Cigarette smoking induces functional anti- protease deficiency in the lower respiratory tract of humans. Science 206(4424):1315-1316. December 1979. GADEK, J.E., FELLS, G.A., ZIMMERMAN, R.L., RENNARD, S.L, CRYSTAL, R.G. Anti- elastases of the human alveolar structures: Implications for the protease-antiprotease theory of emphysema. Journal of Clinical Investigation 68(4):889-898, October 1981. GALDSTON, M., LEVYTSKA, V., SCHWARTZ, M.S., MAGNUSSON, B. Ceruloplasmin. Increased serum concentration and impaired antioxidant activity in cigarette smokers, and ability to prevent suppression of elastase inhibitory capacity of alpha;-proteinase inhibitor. American Review of Respiratory Disease 129:258-263, 1984. GERRARD, J.W., COCKCROFT, D.W., MINK, J.T., COTTON, D.J.. POONAWALA, R.. DOSMAN, J.A. Increased nonspecific bronchial reactivity in cigarette smokers with normal lung function. American Review of Respiratory Disease 122(4):577-581, October 1980. GERRARD, J.W., HEINER, D.C.. KO, C.G., MINK, J.. MEYERS, A., DOSMAN, J.A. Immunoglobulin levels in smokers and non-smokers. Annals of Allergy 44(5):261-262, May 1980. GINNS, L.C.,GOLDENHEIM, P.D., MILLER, L.G., BURTON, R.C., GILLICK, L., COLVIN, R.B., GOLDSTEIN, G., KUNG, P.C., HURWITZ, C., KAZEMI, H. T-lymphocyte subsets in smoking and lung cancer. Analysis by monoclonal antibodies and flow cytometry. American Review of Respiratory Disease 126:265-269, 1982. GLEZEN, W.P., DECKER, M.. PERROTTA. D.M. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978- 1981. American Review of Respiratory Disease 136:550-555, 1987. GOLDSMITH, J.R., HECHTER, H.H., PERKINS, N.M., BORHANI, N.O. Pulmonary func- lion and respiratory findings among longshoremen. American Review of Respiratory Disease 86(6):867-874, December 1962. GOODMAN, R.M., YERGIN, B.M.. LANDA, J.F.. GOLINVAUX, M.H., SACKNER, M.A, Relationship of smoking history and pulmonary function tests to trachael mucous velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic bronchitis. American Review of Respiratory Disease \7(2):205-214, February 1978. GOTOH, T., UEDA, S.. NAKAYAMA, T., TAKISHITA, Y., YASOUKA, S., TSUBURA. E. Protein components of bronchoalveolar lavage fluids from non-smokers and smokers. European Journal of Respiratory Diseases 64(5):369-377, July 1983. GREENING, A.P., LOWRIE, D.B. Extracellular release of hydrogen peroxide by human alveolar macrophages: The relationship to cigarette smoking and lower respiratory tract infections. Clinical Science 65:66 1-664, 1983. GROSS, P., PFITZER, E.A.. TOLKER, E., BABYAK, M.A., KASCHAK, M. Experimental emphysema. Its production with papain in normal and silicotic rats. Archives of Environmen- tal Health 11(1):50-58, July 1965. GRUCHOW, H.W., HOFFMANN, R.G., MARX, J.J. JR.. EMANUEL, D.A., RIMM, A.A. Precipitating antibodies to farmer’s lung antigens in a Wisconsin farming population. American Review of Respiratory Disease 124:411-415, 1981. GULSVIK, A., FAGERHOL, M.K. Smoking and immunoglobulin levels. (Letter.) Lancet 1:449, February 24, 1979. HALLGREN, R., NOU, E., ARRENDAL, H., HIESCHE, K. Smoking and circulating IgE in bronchial carcinoma. Acta Medica Scandinavica 211:269-273, 1982. HAMMOND, E.C. Evidence on the effects of giving up cigarette smoking. American Journal of Public Health 55(5):682-691, May 1965. 356 HAMMOND, E.C., HORN, D. Smoking and death rates—Report on forty-four months of followup of 187.783 men. Journal of the American Medical Association 166(11):1294—1308. March 15, 1958, HARRIS, J.0.. OLSEN, G.N.. CASTLE, J.R.. MALONEY. A.S. Comparison of proteolytic enzyme activity in pulmonary alveolar macrophages and blood leukocytes in smokers and nonsmokers. American Review of Respiratory Disease 111(6):579-586, May 1975. HARRIS, J.0., SWENSON, E.L.W.. JOHNSON, J.E. Human alveolar macrophages: Com- parison of phagocytic ability, glucose utilization, and ultrastructure in smokers and non- smokers. Journal of Clinical Investigations 49(11):2086-2096, November 1970. HAWTHORNE, V.M.. FRY. J.S.. Smoking and health: The association between smoking behaviour, total mortality, and cardiorespiratory disease in west central Scotland. Journal of Epidemiology and Community Health 32:260-266, 1978. HAYNES, W.F. JR., KRSTULOVIC, V.J., BELL, A.L. JR. Smoking habit and incidence of respiratory tract infections in a group of adolescent males. American Review of Respiratory Disease 93(5):780-785, May 1966, HEISKELL, C.L., MILLER. J.N.. ALDRICH, H.J.. CARPENTER, C.M. Smoking and serologic abnormalities. Journal of the American Medical Association 181:88-91, 1962. HERSEY, P., PRENDERGAST, D., EDWARDS. A. Effects of cigarette smoking on the immune system. FoHow-up studies in norma subjects after cessation of smoking. Medical Journal of Australia 2(9):425-429, October 29, 1983. HIGENBOTTAM, T., SHIPLEY. M.J.. CLARK. TJ.H.. ROSE. G. Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Luncet 1(8165):409-412, February 23, 1980. HIGENBOTTAM, T.W., FEYERABAND, C., CLARK. T.J.H. Cigarette smoking in asthma. British Journal of Diseases of the Chest 714:279-284, 1980. HIGGINS, I.T.T., HIGGINS, M.W., LOCKSHIN, M.D., CANALE,. N. Chronic respiratory diseases in mining communities in Marion County, West Virginia. British Journal of Industrial Medicine 25:165, 1968. HIGGINS, M.W., KELLER, J.B., METZNER. H.L. Smoking. socioeconomic status and chronic respiratory disease. American Review of Respiratory Disease 116(3):403-410, September 1977. HIGGINS, M.W., KJELSBERG, M. Characteristics of smokers and nonsmokers in Tecumseh, Michigan. II. The distribution of selected physical measurements and physiologic variables and the prevalence of certain diseases in smokers and nonsmokers. American Journal of Epidemiology 86(1):60—-77, 1967. HILLERDAHL, G., RYLANDER, R. Asthma and cessation of smoking. Clinical Allergy 14:45-47, 1984. HOIDAL, J.R., FOX, R.B., LEMARBRE, P.A., TAKIFF, H.E., REPINE, JE. Oxidative metabolism of alveolar macrophages from young asymptomatic cigarette smokers. Increased superoxide anion release and its potential consequences. Chest 77(2. Supplement):270—27 1, February 1980. HOIDAL, J.R., FOX, R.B., TAKIFF, H.E., REPINE, J.E. Alveolar macrophages (AM) from young, asymptomatic cigarette smokers (CS) and nonsmokers (NS) use equal amounts of oxygen (O2~) and glucose a-4ey, but smoker AM make more superoxide anion. (Abstract.) American Review of Respiratory Disease 119(4, Supplement):222A, April 1979, HOIDAL, J.R., NIEWOEHNER, D.E. Lung phagocyte recruitment and metabolic alterations induced by cigarette smoke in humans and in hamsters. American Review of Respiratory Disease 126:548—552, 1982. HOLT, P.G. Immune and inflammatory function in cigarette smokers. Thorax 42:241-249, 1987. 357 HOLT. P.G.. KEAST. D. Environmentally induced changes in immunological function: Acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriological Reviews 41(1):205-216. March 1977. HORN. B.R.. ROBIN, E.D.. THEODORE, J.. VAN KESSEL. A. Total eosinophil counts in the management of bronchial asthma. New England Journal of Medicine 292(22):1152—-1155, May 29, 1975. HUGHES, D.A., HASLAM. P.L.. TOWNSEND. P.J.. TURNER-WARWICK, M. Numerical and functional alterations in circulatory lymphocytes in cigarette smokers. Clinical and Experimental Immunology 61(2):459-466, August 1985. HUGHES. J.A.. HUTCHISON, D.C.S.. BELLAMY, D., DOWD, D.E.. RYAN, K.C.. HUGH- JONES, P. The influence of cigarette smoking and its withdrawal on the annual change of lung function in pulmonary emphysema. Quarterly Journal of Medicine 51(202):115-124, Spring 1982. HUHTI. E., IKKALA, J. A 10-year follow-up study of respiratory symptoms and ventilatory function in a middle-aged rural population. European Journal of Respiratory Diseases 61 (1): 33-45. February 1980. HUNNINGHAKE, G.W., CRYSTAL. R.G. Cigarette smoking and lung destruction. Accu- mulation of neutrophils in the lungs of cigarette smokers. American Review of Respiratory Disease 128(5):833-838, November 1983. HUNNINGHAKE. G.W.. GADEK, J.E.. KAWANAMI, O., FERRANS. V.J..CRYSTAL.R.G. Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage. American Journal of Pathology 97:149~206. 1979. HYLAND. R.H., KRASTINS, R.R.. ASPIN. N.. MANSELL, A.. ZAMEL, N. Effect of body position on carbon monoxide diffusing capacity in asymptomatic smokers and nonsmokers. American Review of Respiratory Disease 117(6):1045-1053, June 1978. INGRAM. R.H. JR..O°CAIN, C.F. Frequency dependence of compliance in apparently healthy smokers versus nonsmokers. Bulletin de Physiopathologie Respiratoire 7(1):195—210, January—February 1971. INGRAM, R.H. JR.. SCHILDER. D.P. Association of a decrease in dynamic compliance with a change in gas distribution. Journal of Applied Physiology 23(6):91 1-916, December 1967. JANOFF, A., WHITE, R.. CARP. H., HAREL. S.. DEARING. R.. LEE, D. Lung injury induced by leukocytic proteases. American Journal of Pathology 97(1):1 11-129, October 1979. JONES. J.G.. MINTY, B.D.. LAWLER, P.. HULANDS. G.L.. CRAWLEY. J.C.W.. VEALL. N. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1(8159):66-68, January 12, 1980. JOSEPH. M.. TONNEL, A.B.. CAPRON, A.. VOISIN.C. Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. Clinical and Experimental Immunology 40:416-422, 1980. KABIRAJ, M.U.. SIMONSSON,. B.G.. GROTH, S.. BJORKLUND. A.. BULOW. K.. LIN- DELL. S.E. Bronchial reactivity, smoking, and alpha-l-antitrypsin. A population-based study of middle-aged men. American Review of Respiratory Disease 126:864-869, 1982. KANNER, R.E., RENZETTI. A.D.. STANISH. W.M.. BARKMAN. H.W... KLAUBER. MR. Predictors of survival in subjects with chronic airflow limitation. American Journal of Medicine 74:249-255, February 1983. KARK. J.D.. LEBIUSH, M. Smoking and epidemic influenza-like illness in female military recruits: A brief survey. American Journal of Public Health 71($):530-532. May 1981. KARK, J.D.. LEBIUSH, M.. RANNON. L. Cigarette smoking as a risk factor for epidemic A(H{N1) influenza in young men. New England Journal of Medicine 307(.17):1042-1046, October 21, 1982. hand nm oe KASZUBOWSKI. P.. WYSOCKI. J.. MACHALSKI, M. T-lymphocytes and their T-gamma and T-mu subpopulations in cigarette smokers. Polskie Archiwum Medvcevny Wewnetrzne] 65(2):101-105, February 1981. KAUFFMANN, F.. NEUKIRCH. F., KOROBAEFF. M.. MARNE. M.-J.. CLAUDE. J.-R.. LELLOUCH. J. Eosinophils. smoking. and lung function. An epidemiologic survey among 912 working men. American Review of Respiratory Disease 134(6):1 172-1175. December 1986. KAUFFMANN. F.. QUERLEUX. E.. DROUET. D.. LELLOUCH. J.. BRILLE. D. Evolution du vems en [2 ans et tabagisme chez 556 travailleurs de la region parisienne. [Twelve year FEV, changes and the smoking habits among 556 workers in the Paris area.| Bulletin Européen de Physiopathologie Respiratoire {$:723-737, 1979, KILBURN, K.H.. WARSHAW, R.. THORNTON, J.C. Asbestos diseases and pulmonary symptoms and signs in shipyard workers and their families in Los Angeles. Archives of Internal Medicine 146:22 13-2220. November 1986, KIVILOOG, J.. IRNELL. L.. EKLUND, G. The prevalence of bronchial asthma and chronic bronchitis in smokers and non-smokers in a representative local Swedish population. Sccs- dinavian Journal of Respiratory Diseases 55:262-276, 1974. KLEIN. R.C..SALVAGGIO. J.E. Nonspecificity of the bronchoconstricting effect of histamine and acetyl-beta-methylcholine in patients with obstructive airway disease. Journal of Allergy 37(3): 158-168, March 1966. KNOWLES. G.K., TAYLOR. P.. TURNER-WARWICK, M. A comparison of antibody responses to admune inactivated influenza vaccine in serum and respiratory secretions of healthy non-smokers. healthy cigarette-smokers and patients with chronic bronchitis. British Journal of Diseases of the Chest 75:283-290. 1981. KNUDSON, R.J.. BLOOM, J.W., KNUDSON. D.E.. KALTENBORN, W.T. Subclinical effects of smoking. Physiologic comparison of healthy middle-aged smokers and nonsmokers and interrelationships of lung function measurements. Chest 86:20-29, July 1984. KNUDSON. R.J., BURROWS, B.. LEBOWITZ. M.D. The maximal expiratory flow-volume curve: Its use in the detection of ventilatory abnormalities in a population study. American Review of Respiratory Disease |14(3):871-879, November 1976. KNUDSON. R.J.. KALTENBORN, W.T.. BURROWS. B. The effects of cigarette smoking and smoking cessation on the carbon monoxide diffusing capacity of the lung in asymptomatic subjects. American Review of Respiratory Disease 140(3):645-65 1. 1989. KORN, R.J.. DOCKERY, D.W., SPEIZER, F.E., WARE, J.H., FERRIS. B.G. JR. Occupational exposures and chronic respiratory symptoms. A population-based study. American Review of Respiratory Disease 136:298-304, 1987. KOSMIDER,. S.. FELUS. E., WYSOCKI. J. Evaluation of some humoral resistance deter- minants in cigarette smokers. Polski Tygodnik Lekarski 28(2):47-50, January 8. 1973. KRUMHOLZ., R.A., HEDRICK, E.C. Pulmonary function differences in normal smoking and nonsmoking, middle-aged, white-collar workers. American Review of Respiratory Disease 107(2):225-230, February 1973. KUSAKA, H.. HOMMA, Y., OGASAWARA, H.. MUNAKATA. M., TANIMURA, K.. UKITA, H., DENZUMI_N.. KAWAKAML, Y. Five-year follow-up of Micropolyspora faeni antibody in smoking and nonsmoking farmers. American Review of Respiratory Disease 140(3):695-699, 1989. LABEDZKI,L., MAGNUSSEN, H., HARTMANN. V.,LOOS, U., MACKES.G.. SCHWABE. H.. BRAUMSCHWEIG, D., TIPPELMANN. G., FROST-HENSEL, E. Bronchoalveolar lavage in persons with lung disease: Cytology and macrophage function. Praxis und Klinik der Pneumologie 37(1):832-835, October 1983. LANGE, P., GROTH. S.. NYBOE. J.. MORTENSEN, J.. APPLEYARD, M., JENSEN, G.. SCHNOHR,. P. Effects of smoking and changes in smoking habits on the decline of FEV). European Respiratory Journal 2:811-816, 1989. LAURELL, C.-B.. ERIKSSON. S. The electrophoretic ;-globulin pattern of serum in |-antitryp- sin deficiency. Scandinavian Journal of Clinical and Laboratory Investigation \5(2):132—- 140, 1963. LEBOWITZ, M.D.. BURROWS. B. Quantitative relationships between cigarette smoking and chronic productive cough. International Journal of Epidemiology 6(2):107-113, 1977. LEEDER, S.R., COLLEY. J.R.T., CORKHILL, R., HOLLAND, W.W. Change in respiratory symptom prevalence in adults who alter their smoking habits. American Journal of Epidemiology 105(6):522-529, 1977. LEITCH. A.G., LUMB, E.M.. KAY. A.B. Mediators of hypersensitivity in the sputum of young. symptomatic cigarette smokers. Clinical Allergy 11:257-262, 1981. LOURENCO. R.V.. KLIMEK, M.F.. BOROWSKI. C.J. Deposition and clearance of 2% particles in the tracheobronchial tree of normal subjects —Smokers and nonsmokers. Journal of Clinical Investigation 50: 1411-1420, 1971. MACKENZIE, J.S.. MACKENZIE, I.H.. HOLT, P.G. The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines. Journal of Hygiene 77(3):409-417, December 1976. MALO, J.L.. FILIATRAULT. S.. MARTIN, R.R. Bronchial responsiveness to inhaled methacholine in young asymptomatic smokers. Journal of Applied Physiology 52(6):1464— 1470, June 1982. MANEFREDA, J.. NELSON. N.. CHERNIACK. R.M. Prevalence of respiratory abnormalities in a rural and an urban community. American Review of Respiratory Disease 117-215-226, 1978. MARCQ. M., MINETTE. A. Lung function changes in smokers with normal conventional spirometry. American Review of Respiratory Disease 114:723-738. 1976. MARCUS, E.B., BUIST, A.S.. MACLEAN. C.J.. YANO. K. Twenty-year trends in mortality from chronic obstructive pulmonary disease: The Honolulu heart program. American Review of Respiratory Disease 140(Supplement):S64—-S68, 1989. MARTIN, R.R., LINDSAY. D.. DESPAS. P.. BRUCE, D.. LEROUX. M., ANTHONISEN. N.R.. MACKLEM. P.T. The early detection of airway obstruction. American Review of Respiratory Disease 111:119-125, 1975. MARTIN. R.R.. WARR.G.A. Cigarette smoking and human pulmonary macrophages. Hospi- tal Practice 12(9):97-104, September 1977. MARTINEZ. F.D.. ANTOGNONI. G.. MACRI. F., BONCI. E.. MIDULLA. F.. DE CASTRO. G.. RONCHETTI. R. Parental smoking enhances branchial responsiveness in nine-year-old children. American Review of Respiratory Disease 138:518-523, 1988. MASON, G.R.. USZLER. J.M.. EFFROS. R.M.. REID. E. Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking. Chest 83(1):6-11, January 1983. MCCARTHY. D.S.. CRAIG. D.B.. CHERNIACK. R.M. Effect of modification of the smoking habit on lung function. American Review of Respiratory Disease 114(1):103-113, July 1976. MCSHARRY. C., BANHAM. S.W.. BOYD. G. Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clinical Allergy 15(5):487-—-494. September 1985. MCSHARRY. C.. BANHAM. S.W.. LYNCH. P.P.. BOYD. G. Antibody measurement in extrinsic allergic alveolitis. European Journal of Respiratory Diseases 65(4):259-265. May 1984. MCSHARRY. C.. WILKINSON. P.C. Cigarette smoking and the antibody response to inhaled antigens. /nimunology Today 7:98-102, 1986. 360 MICHAELS. R.. SIGURDSON, M.. THURLBECK., S.. CHERNIACK. R. Elastic recoil of the lung in cigarette smokers: The effect of nebulized bronchodilator and cessation of smoking. American Review of Respiratory Disease | 19(5):707-716, May 1979, MILLER, A.. THORNTON, J.C. ANDERSON, H.A.. SELIKOFF. LJ. Clinical respiratory abnormalities in Michigan. Prevalence by sex and smoking history in a representative sample of the adult population. Chest 94(6): 1187-1194, December 1988. MILLER, A.. THORNTON, J.C, WARSHAW, R.. ANDERSON. H.. TEIRSTEIN. A.S.. SELIKOFF, IJ. Single breath diffusing capacity ina representative sample of the population of Michigan, a large industrial state. American Review of Respiratory Disease 127(3):270— 277, March 1983, MILLER, L.G., GOLDSTEIN, G.. MURPHY, M.. GINNS, L.C. Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest 82(5):526-529, 1982. MINTY, B.D., JORDAN, C.. JONES, J.G. Rapid improvement in abnormal pulmonary epithelial permeability after stopping cigarettes. British Medical Journal 282:1183-1186, April 11, 1981. MORGAN, D.C.. SMYTH. JT. LISTER, R.W.. PETHYBRIDGE. RJ. Chest symptoms and farmer's lung: A community survey. British Journal of Industrial Medicine 30(3):259-265, July 1973, MORGAN. D.C.. SMYTH, LT. LISTER, R.W.. PETHYBRIDGE. RJ. GILSON, J.C... CAL- LAGHAN, P.. THOMAS. G.O. Chest symptoms in farming communities with special reference to farmer's lung. British Journal of industrial Medicine 32(3):228-234. August 1975, MUELLER, R.E., KEBLE, D.L., PLUMMER, I, WALKER, S.H. The prevalence of chronic bronchitis, chronic airway obstruction, and respiratory symptoms in a Colorado city. American Review of Respiratory Disease 103:209-228, 1971, NAGAI, A., WEST, W.W., THURLBECK, W.M. The National Institutes of Health intermittent positive-pressure breathing trial: Pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction. American Review of Respiratory Disease 132(5):946-953, November 1985. NIELSEN, H. A quantitative and qualitative study of blood monocytes in smokers. European Journal of Respiratory Diseases 66(5):327~—332, May 1985. NIEWOEHNER, D.E., KLEINERMAN, J., RICE, D.B. Pathologic changes in the peripheral airways of young cigarette smokers. New England Journal of Medicine 291(15):755-758. October 10, 1974, NOBLE, R.C., PENNY. B.B. Comparison of leukocyte count and function in smoking and nonsmoking young men. Infection and Immunity 12(3):550-555, September 1975, O’CONNOR, G.T., SPARROW, D., WEISS, S.T. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. American Review of Respiratory Disease 140:225-252, 1989. ONARI, K., SADAMOTO, K., TAKAISHI, M., INAMIZU, T., IKUTA, T., YORIOKA., N., ISHIOKA, S., YAMAKIDO, M., NISHIMOTO, Y. Immunological studies on cigarette smokers. Part II. Cell mediated immunity in cigarette smokers and the influence of the water-soluble fraction of cigarette smoke (WSF) on the immunity of mice. Hiroshima Journal of Medical Science 29(2):29-34, June 1, 1980. PAOLETTI, P., CAMILLL A.E., HOLBERG, C.J., LEBOWITZ, M.D. Respiratory effects in relation to estimated tar exposure from current and cumulative cigarette consumption. Chest 88(6):849-855, December 1985. PARKER, C.D., BILBO, R.E., REED, C.E. Methacholine aerosol as test for bronchial asthma. Archives of Internal Medicine | 15(4):452-458, April 1965. 361 PARNELL. J.L.. ANDERSON. D.O.. KINNIS, C. Cigarette smoking and respiratory infections in a class of student nurses. New England Journal of Medicine 274(18):980-984, May 5, 1966. PAYNE, M., KJELSBERG. M. Respiratory symptoms. lung function. and smoking habits in an adult population. American Journal of Public Health §4(2):261-277. February 1964. PEAT. J.K.. WOOLCOCK. A.J.. CULLEN. K. Rate of decline of lung function in subjects with asthma, European Journal of Respiratory Diseases 70(3):171-179, March 1987. PETERS, J.M., FERRIS. B.G. JR. Smoking and morbidity in a college-age group. American Review of Respiratory Disease 95(5):783-789, May 1967. PETO, R., SPEIZER, F.E.. COCHRANE. A.L.. MOORE. F.. FLETCHER, C.M., TINKER. C.M.. HIGGINS, LT.T.. GRAY. R.G.. RICHARDS. S.M.. GILLILAND. J.. NORMAN- SMITH. B. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion. to mortality from chronic lung disease. Results from 20 years of prospective observation. American Review of Respiratory Disease 128(3):491—500. 1983. PHAM. Q.T.. MUR, J.M.. CHAU. N.. GABIANO, M.. HENQUEL. .C.. TECULESCU. D. Prognostic value of acetylcholine challenge test: A prospective study. British Journal of Industrial Medicine 41:267-271, 1984. POLLARD. R.B., MELTON. L.J. IH. HOEFFLER, D.F.. SPRINGER. G.L.. SCHEINER, E.F. Smoking and respiratory illness in military recruits. Archives of Environmental Health 30:533-537, 1975. POSTMA. D.S.. DE VRIES. K.. KOETER. G.H.. SLUITER. H.J. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. American Review of Respiratory Disease 134(2):276-280, August 1986. POSTMA. D.S.. GIMENO, F.. VAN DER WEELE. L.T.. SLUITER. H.J. Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: The importance of reversibility. European Journal of Respiratory Diseases 67(5):360-368. November 1985. POUKKULA. A.. HUHTI.E.. MAKARAINEN. M. Chronic respiratory disease among workers ina pulp mill. A ten-year follow-up study. Chest 81(3):285-289, March 1982. PRE. J.M.. BLADIER. D.. BATTESTI. J.-P. Cytological and immunochemical reactions of human alveoli to tobacco aggression: Importance and characteristics. IRCS Journal of Medical Science: Biochemistry 8(9):637-638, 1980. PRIDE, N.B.. TATTERSALL. S.F.. BENSON. M.K.. HUNTER. D.. MANSELL, A.. FLETCHER. C.M.. PETO. R. Peripheral lung function and spirometry in male smokers and exsmokers. Chest 77(2. Supplement):289-290, February 1980. RAMAN. A.S.. SWINBURNE, A.J., FEDULLA. A.J. Pneumococcal adherence to the buccal epithelial cells of cigarette smokers. Chest 83:23-27. 1983. RAMSDALE. E.H.. MORRIS. M.M.. ROBERTS. R.S.. HARGREAVE. F.E. Bronchial respon- siveness to methacholine in chronic bronchitis: Relationship to airflow obstruction and cold air responsiveness. Thorax 39(12):912-918, December 1984. RAMSDELL. J.W.. NACHTWEY. F.J.. MOSER. K.M. Bronchial hyperreactivity in chronic obstructive bronchitis. American Review of Respiratory Disease 126(5):829-832. November 1982. RAZMA, A.G.. LYNCH, J.P. III]. WILSON, B.S.. WARD. P.A.. KUNKEL. S.L. Human alveolar macrophage activation and DR antigen expression in cigarette smokers. Chest 85(6, Supplement):41S—43S, June 1984. REYNOLDS. H.Y.. NEWBALL. H.H. Aalysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. Journal ef Laboratory and Clinical Medicine 84(4):559— 573, October 1974. 362 RICHARDS, S.W., PETERSON, P.K.. VERBRUGH. H.A.. NELSON. R.D.. HAMMER- SCHMIDT. D.E., HOIDAL, J.R. Chemotactic and phagocytic responses of human alveolar macrophages to activated complement components. /nfection and Immunity 43(2):775-778, February 1984. RICKEN, B., SCHOUTEN, J.P., WEISS. S.T.. SPEIZER. F.E.. VAN DER LENDE. R. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. American Review of Respiratory Disease 136:62-68, 1987. ROBERTSON, J., CALDWELL. J.R., CASTLE, J.R.. WALDMAN, R.H, Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. Journal of Immunology 117(3):900-903. September 1976. ROBERTSON, M.D.. BOYD. D.E.. FERNIE. J.M.. DAVIS, I.M.G. Some immunological studies on coalworkers with and without pneumonoconiosis. American Journal of Industrial Medicine 4(3):467-476, 1983. ROGOT, E., MURRAY. J.L. Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Reports 95(3):213—222, May-June 1980. SAETTA, M.. GHEZZO, H., KIM, W.D., KING, M., ANGUS, G.E.. WANG, N.-S.. COSIO. M.G. Loss of alveolar attachments in smokers: A morphometric correlate of lung function impairment. American Review of Respiratory Disease 132:894—900, 1985. SCHACHTER, E.N., DOYLE, C.A.. BECK, GJ. A prospective study of asthma in a rural community. Chest 85(5):623-630, May 1984. SCHENKER, M.B., SAMET, J.M., SPEIZER, F.E. Effect of cigarette tar content and smoking habits on respiratory symptoms in women. American Review of Respiratory Disease 125:684-690, 1982. SCHLESINGER, Z., GOLDBOURT. U., MEDALIE. J.H.. RISS, E.. NEUFELD. H.N.. ORON. D. Pulmonary function and respiratory disease among adult male Israelis. Variations by age and birth place. /srae/ Journal of Medical Sciences 8(7):957_-964. July 1972. SHARP, J.T., PAUL, O., MCKEAN, H.. BEST, W.R. A longitudinal study of bronchitic symptoms and spirometry in a middle-aged. male, industrial population. American Review of Respiratory Disease 108(5):1066—-1077, November 1973. SIMANI, A.S., INOUE, S., HOGG, J.C. Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. Laboratory Investigation 31(1):75-81, July 1974. SIMONSSON, B.G., ROLF, C. Bronchial reactivity to methacholine in ten non-obstructive heavy smokers before and up to one year after cessation of smoking. European Journal of Respiratory Diseases 63:526—534, 1982. SMART, Y.C., COX, J., ROBERTS, T.K., BRINSMEAD, M.W., BURTON. R.C. Differential effect of cigarette smoking on recirculating T lymphocyte subsets in pregnant women. Journal of Immunology 137(1):1-3, July 1, 1986. SNIDER, G.L. Chronic bronchitis and emphysema. In: Murray, J.F.. Nadel, J.A. (eds.) Textbook of Respiratory Medicine. Philadelphia: W.B. Saunders Co., 1988, pp. 1069-1 106. SNIDER. G.L. Chronic obstructive pulmonary disease: A definition and implications of structural determinants of airflow obstruction for epidemiology. American Review of Respiratory Disease, 140(3, Supplement):S3-S8, September 1989. SPARROW, D., O°CONNOR, G., COLTON, T., BARRY, C.L., WEISS, S.T. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function. American Review of Respiratory Disease 135:1255— 1260, 1987. SPEIZER, F.E., FAY. M.E., DOCKERY, D.W.. FERRIS, B.G. JR. Chronic obstructive pulmonary disease mortality in six U.S. cities. American Review of Respiratory Disease 140:S49-S55,1989. SPEIZER, F.E.. TAGER. I.B. Epidemiology of chronic mucus hypersecretion and obstructive airways disease. Epidemiologic Reviews 1:124-142, 1979, 363 STEIN, R., EVANS, S.. MILNER. R.. RAND. C.. DOLOVICH. J. Isotopic and enzymatic IgE assays in non-allergic subjects. AHergy 38(6):389-398, August 1983. SUCIU-FOCA, N.. MOLONARO, A., BUDA. J.. REEMTSMA. K. Cellular immune respon- siveness in cigarette smokers. (Letter.) Lancet 1:1062, May 25, 1974. TABONA, M., CHAN-YEUNG., M.. ENARSON, D., MACLEAN, L.. DORKEN, E.. SCHUL- ZER. M. Host factors affecting longitudinal decline in lung spirometry among grain elevator workers. Chest 85(6):782-786, June 1984. TAGER., 1.B., SEGAL, M.R., SPEIZER. F.E.. WEISS. S.T. The natural history of forced expiratory volumes—Effect of cigarette smoking and respiratory symptoms. American Review of Respiratory Disease 138:837-838, 1988. TAGER., I.B., WEISS. S.T.. MUNOZ, A., ROSNER, B.. SPEIZER, F.E. Longitudinal study of the effects of maternal smoking on pulmonary function in children. New England Journal of Medicine 309:699-703, September 22, 1983. TASHKIN. D.P.. CLARK, V.A.. COULSON, A.H., SIMMONS. M., BOURQUE, L.B., REEMS. C.. DETELS. R.. SAYRE, J.W.. ROKAW, S.N. The UCLA population studies of chronic obstructive respiratory disease. VIL. Effects of smoking cessation on lung function: A prospective study of a free-living population. American Review of Resptratory Disease 130(5):707-715. November 1984. TAYLOR. R.G.. GROSS. E.. JOYCE, H.. HOLLAND, F.. PRIDE, N.B. Smoking, allergy, and the differential white blood cell count. Thorax 40:1 7~22. 1985. TAYLOR, R.G.. JOYCE. H.. GROSS. E., HOLLAND, F.. PRIDE. N.B. Bronchial reactivity to inhaled histamine and annual rate of decline in FEV) in male smokers and ex-smokers. Thorax 40:9-16, 1985. TECULESCU, D.B., STANESCU, D.C. Lung diffusing capacity. Normal values in male smokers and non-smokers using the breath-holding technique. Scandinavian Journal of Respiratory Diseases 51(3):137-149, 1970. THOMSON, MLL.. PAVIA, D. Long-term tobacco smoking and mucociliary clearance from the human lung in health and respiratory impairment. Archives of Environmental Health 26: 86-89, February 1973. THURLBECK, W.M. Chronic airflow obstruction in lung disease. In: Bennington. J.L. (ed.) Major Problems in Pathology, Volume 5S. Philadelphia: W.B. Saunders Company, 1976. pp. 235-287. TOCKMAN. M.S., COMSTOCK. G.W. Respiratory risk factors and mortality: Longitudinal studies in Washington County, Maryland. American Review of Respiratory Disease |40(Sp- plement):S56S63, 1989. TOLLERUD.D.J..CLARK.J.W.. BROWN.L.M..NEULAND.C.Y..MANN.D.L..PANKIW- TROST. L.K.. BLATTNER. W.A.. HOOVER. R.N. The effects of cigarette smoking on T cell subsets. A population-based survey of healthy Caucasions. American Review of Respiratory Disease \39:1446-145 1, 1989. TOWNSEND. M.C.. DUCHENE. A.G.. MORGAN. J.. BROWNER. W.S. Cigarette smoking intervention in the Multiple Risk Factor Intervention Trial: Results and relationships to other outcomes. Pulmonary function in relation to cigarette smoking and smoking cessation. Preventive Medicine, in press. TRAVER. G.A.. CLINE. M.G.. BURROWS, B. Predictors of mortality in chronic obstructive pulmonary disease: A 15-year follow-up study. American Review of Respiratory Disease 119(6):895-902, June 1979, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. The Health Consequences of Smoking: Chronic Obstructive Lung Disease. A Report of the Surgeon General. US. Department of Health and Human Services, Public Health Service, Office on Smoking and Health. DHHS Publication No. (PHS) 84-50205, 1984. 364 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. The Health Consequences of Smoking: Cancer and Chronic Lung Disease in the Workplace. A Report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health. DHHS Publication No. (PHS) 85-50207, 1985. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. The Health Consequences of Javoluntary Smoking. A Report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service. Centers for Disease Control. DHHS Publication No. (CDC) 87-8398, 1986. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Reducing the Health Conse- quences of Smoking: 25 Years of Progress. A Report of the Surgeon General. US. Department of Health and Human Services. Public Health Service. Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office an Smoking and Health. DHHS Publication No. (CDC) 89-8411, 1989. U.S. DEPARTMENT OF HEALTH, EDUCATION. AND WELFARE. The Health Conse- quences of Smoking. A Report of the Surgeon General: 1971, U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Ad- ministration. DHEW Publication No. (HSM) 71-7513, 1971. U.S. DEPARTMENT OF HEALTH. EDUCATION, AND WELFARE. Smoking and Health: A Report of the Surgeon General. U.S. Department of Health. Education. and Welfare. Public Health Service, Office of the Assistant Secretary for Health. Office on Smoking and Health. DHEW Publication No. (PHS) 79-50066, 1979. U.S. PUBLIC HEALTH SERVICE. Smoking and Health. Report of the Advisory Conmmittee to the Surgeon General of the Public Health Service. U.S. Department of Health, Education. and Welfare, Public Health Service, Center for Disease Control. PHS Publication No. 1103. 1964. VAN DER LENDE, R.. KOK, T.J.. REIG, R.P., QUANJER. P.H.. SCHOUTEN, J.P.. ORIE,. N.G.M. Diminutions de cv et de vems avec le temps: Index des effets du tabagisme et de la pollution de Pair. [Decreases in VC and FEV, with time: Indicators for effects of smoking and air pollution.) Bulletin Européen de Physiopathologie Respiratoire 17:775-792. 981. VAN GANSE, W.F., FERRIS, B.G. JR., COTES, J.E. Cigarette smoking and pulmonary diffusing capacity (transfer factor). American Review of Respiratory Disease 105(1):30-41, January 1972. VELLUTI, G.. CAPELLI, O., LUSUARDI. M.. BRAGHIROLI, A.. PELLEGRINO, M., MILANTI, G., BENEDETTI, L. Bronchoalveolar lavage in the normal lung. First of three parts: Protein, enzymatic and ionic features. Respiration 44(6):403-410, November~Decem- ber 1983. VILLIGER, B.. BROEKELMANN,T.. KELLEY. D.. HEYMACH,G.J. IIT, MCDONALD.J.A. Bronchoalveolar fibronectin in smokers and non-smokers. American Review of Respiratory Disease 124(5):652-654, November 1981. VOLLMER, W.M., JOHNSON, L.R., BUIST, A.S. Relationship of response to a bronchodilator and decline in forced expiratory volume in one second in population studies. American Review of Respiratory Disease 132:1186-1193, 1985. VOS-BRAT, L.C., RUMKE, P.H. Immunoglobuline concentraties. PHA reacties van lym- focyten tn vittro en enkele antistof titers van gezonde rokers. /aarhoek Van Kankeronderzoek en Kankerbestrijding in Nederland 19:49-53, 1969. WARR, G.A.. MARTIN, R.R. Chemotactic responsiveness of human alveolar macrophages: Effects of cigarette smoking. /nfection and Immunity 9(4):769-771, April 1974. WARR,G.A., MARTIN, R.R. Immune receptors of human alveolar macrophages: Comparison between cigarette smokers and nonsmokers. Journal of the Reticuloendothelial Society 22(3):181-187, September 1977. 365 WARREN, C.P.W.. HOLFORD-STREVENS., V.. WONG, C., MANFREDA. J. The relation- ship between smoking and total immunoglobulin E levels. Journal of Allerey and Clinical Immunology 69(4):370-375, 1982. WEISS. S.T.. TAGER, L.B.. MUNOZ, A.. SPEIZER, F.E. The relationship of respiratory infections in early childhood to the occurrence of increased levels of bronchial responsiveness and atopy. American Review of Respiratory Disease 131(4):573—-578, April 1985. WEISS. W., BOUCOT. K.R.. COOPER. D.A.. CARNAHAN, W.J. Smoking and the health of older men. {I. Smoking and ventilatory function. Archives of Environmental Health 7:538— 553, November 1963. WELTY, C.. WEISS. S.T.. TAGER, I.B.. MUNOZ, A., BECKER, C.. SPEIZER, F.E.. IN- GRAM. R.H. JR. The relationship of airways responsiveness to cold air. cigarette smoking. and atopy to respiratory symptoms and pulmonary function in adults. Amertcan Review of Respiratory Disease 130:198-203, 1984. WHITEHEAD. R.H.. HOOPER, B.E., GRIMSHAW, D.A.. HUGHES, L.E. Cellular immune responsiveness in cigarette smokers. Lancet !(7868):1232—1233, June 15. 1974. WILHELMSEN, L.. ORHA. I., TIBBLIN. G. Decrease in ventilatory capacity between ages of 50 and 54 in representative sample of Swedish men. British Medical Journal 3:553-556, September 1969. WILHELMSEN, L., TIBBLIN, G. Tobacco smoking in fifty-year-old men. I. Respiratory symptoms and ventilatory function tests. Scandinavian Journal of Respiratory Diseases 47:121-130. 1966. WINGERD, J.. SPONZILLL. E.E. Concentrations of serum protein fractions in white women: Effects of age. weight, smoking. tonsillectomy, and other factors. Clinical Chemistry 23(7): 1310-1317. 1977. WOOLCOCK, A.J.. PEAT. J.K.. SALOME, C.M.. YAN, K.. ANDERSON, S.D., SCHOEF- FEL. R.E., MCCOWAGE, G.. KILLALEA, T. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax 42:361-368. 1987. WOOLF, C.R., SUERO, J.T. The respiratory effects of regular cigarette smoking in women. American Review of Respiratory Disease 103(1):26-37, January 1971. WOOLF, C.R.. ZAMEL. N. The respiratory effects of regular cigarette smoking in women. A five-year prospective study. Chest 78(5):707-713, November 1980. WRIGHT. J.L. Small airway disease: Structure and function. In: Hensley, M.J., Saunders. N.A. (eds.) Clinical Epidemiology of Chronic Obstructive Pulmonary Disease. New York: Marcel Dekker, Inc.. 1989, p. 55. WYATT. R.J.. BRIDGES. R.B.. HALATEK. D.G. Complement levels in cigarette smokers: Elevations of serum concentrations of C5, C9 and Ct-inhbibitor. Journal of Clinical and Laboratory Immunology 6:131-135, 1981. ZAMEL. N., LEROUX, M.. RAMCHARAN. V. Decrease in lung recoil pressure after cessation of smoking. American Review of Respiratory Disease 119(2):205—211, February 1979. ZAMEL. N.. WEBSTER. P.M. Amelioration de la dynamique du debit expiratoire apres arret du tabac. {Improved expiratory airflow dynamics with smoking cessation. ] Bulletin Europeen de Physiopathologie Respiratoire 20:19-23, 1984, ZETTERSTROM. O.. OSTERMAN. K.. MACHADO, L.. JOHANSSON. S.G.O. Another smoking hazard: Raised serum [gE concentration and increased risk of occupational allergy. British Medical Journal 283:12\15~1217, November 7. 1981. 366 CHAPTER 8 SMOKING CESSATION AND REPRODUCTION 367 CONTENTS Part]. Female .... 2... eee een eben evens 37] Pregnancy and Pregnancy Outcome .............0 000000000 cece eee 37] Introduction 2.02... n eee ee 371 Pathophysiologic Framework ......00.0000 000000 c cece eee eee. 371 Nonexperimental Studies ...... 00.00.00 cece eens 374 Fertility and Infertility 0.2.0... cee eee eee 374 Ectopic Pregnancy and Spontaneous Abortion ...................... 375 Fetal, Neonatal, and Perinatal Mortality .........0000.0....00000000.. 376 Birthweight and Gestational Duration ..................0.00000000. 379 Introduction 20... ec cee ee ee eevee es 379 Continued Smoking ..............2 eee eee 38] Cessation Before Conception ............ 0000 c ec ee ee eee eee eee. 382 Cessation After Conception ..........0...0 000000000 eee eee. 383 Birthweight . 2.0.0.2... eee eee 383 Preterm Delivery ..... 00... c ec eee eee ee 386 Complications of Pregnancy ...........0 000 ccc cece eee eee 387 Randomized Trials of Smoking Cessation During Pregnancy ............ 387 Prevalence of Smoking and Smoking Cessation During Pregnancy and Time Trends in Prevalence and Cessation ........0..0.0.0.0.000 0000 e cece 390 Introduction . 0.0... cee eee e eee e nes 390 Prevalence of Smoking and Smoking Cessation...................0. 390 Time Trends in Smoking and Smoking Cessation ................... 393 Estimates of Attributable Risk Percent ...............00.00200002.... 393 Age at Natural Menopause ............00000 000 cece cece eee cece es 396 Introduction 2... cence tee e eens 396 Pathophysiologic Framework .........00.. 00000 ccc eee eee eeees 396 Studies of Former Smokers .........0..00000 0000 cc cece ee eeeeeeeeeeee 398 Part I. Male... 00... e cee e eee eeteveeeees ree . 400 Introduction 2.0... 2 cece ccc cece eee eeeeees 400 Pathophysiologic Framework ......0.00.00000 00 ccc cece cece eee eee eees 400 Sexual Activity and Performance ........00.0000 0.000 ccc cece eee eeeue 401 Sperm Density and Quality ......0000.000000 0000. c cece e eee e ee 404 Conclusions 0. c cece cece eee e ete eteaerreenes 410 References ........... bbe been t tb tet eb vette eneeeerened veeeee ee 4H 369 PART I. FEMALE Pregnancy and Pregnancy Outcome Introduction Since the late 1940s, cigarette smoking during pregnancy has been linked with poor pregnancy outcome (Bermhard 1949; Athayde 1948). Adverse effects of smoking on pregnancy began to receive considerable attention after publication of the results of a study of 7,499 pregnant women in San Bernardino County. CA, in which the rate of prematurity, defined as birthweight less than 2,500 g, was found to be about twice as high among smokers as among nonsmokers during pregnancy (Simpson 1957). Early reports of the Surgeon General (US DHEW 1971, 1973, 1978) concluded that maternal smoking during pregnancy retards fetal growth and is a probable cause of late fetal and infant mortality (US DHEW 1973). The 1977 Report of the Surgeon General (US DHEW 1978) concluded that smoking during pregnancy has dose-response relationships with abruptio placentae. placenta previa, bleeding during pregnancy. premature and prolonged rupture of the membranes, and preterm delivery. The 1979 and 1980 Reports of the Surgeon General (US DHEW 1979, US DHHS 1980) comprehensively reviewed information on the association of maternal smoking with pregnancy outcome and further concluded that the risk of spontaneous abortion in- creases with the amount of smoking and that the risk of sudden infant death syndrome (SIDS) is increased by maternal smoking during pregnancy. The 1980 Report (US DHHS 1980) also indicated the possibility of a link between cigarette smoking and impaired fertility. Two earlier reports of the Surgeon General (US DHEW 1979; US DHHS 1980) concluded that mean gestational duration is not affected by maternal smoking and that data are not sufficient to support a conclusion that maternal smoking increases, decreases, or has no association with risk of congenital malformations. This Section reviews observational studies of smoking cessation and the following reproductive outcomes: fertility and infertility; ectopic pregnancy and spontaneous abortion; fetal, neonatal, and perinatal mortality; birthweight and gestational duration: and complications of pregnancy. Three randomized trials of smoking cessation and pregnancy outcome are described and discussed in detail. Information on the prevalence of smoking during pregnancy and time trends in prevalence is presented, along with estimates of the attributable risk of several pregnancy outcomes. SIDS and congenital malformations are not considered because of the limited information on smoking cessation. Pathophysiologic Framework The effects of smoking that might mediate adverse effects on the developing fetus and on fertility, fetal loss. and pregnancy complications have been reviewed in other publications (Longo 1982; Mattison 1982; US DHHS 1980). These reviews are summarized with attention to the temporal course of the relation between exposure to 37] cigarette smoking and pregnancy outcome as well as the distinction between reversible and irreversible effects of smoking. Reversible effects would be expected to result in similar risks for never smokers and former smokers, whereas irreversible effects would be expected to lead to different risks in both current and former smokers compared with never smokers. Several pathways have been postulated by which tobacco smoke might adversely affect fertility (Mattison 1982) (Table |). These include disturbance of hypothalamic— pituitary function, interference with motility in the female reproductive tract (Chow et al. 1988), and impairment of implantation, all of which are thought to be reversible consequences of exposure to absorbed chemicals in tobacco smoke (principally nicotine). It has also been suggested that smoking results in oocyte depletion through direct toxicity (Mattison 1980), which would have irreversible consequences for fertility. Chow and colleagues (1988) postulated that altered immune function (Hersey, Prendergast, Edwards 1983) may predispose smokers to pelvic inflammatory disease. which in turn can result in permanent scarring and occlusion of the fallopian tubes. Alterations in the neuroendocrine control of ovulation have been suggested to account for increased amenorrhea reported among smokers (Pettersson. Fries, Nillius 1973): this mechanism, as an effect of smoking on fertility. would be reversible. TABLE 1.—Possible mechanisms for the effect of smoking on pregnancy and pregnancy outcome Outcome Possible mechanism Reduced fertility Hormonal effects Impaired tubal motility Impaired implantation Oocyte depletion Altered immunity leading to pelvic inflammatory disease Spontaneous abortion Nicotine toxicity Reduced birthweight Impaired weight gain Nicotine toxicity CO toxicity Increased cyanide teading to impaired vitamin Bi2 metabolism Hy poxia due to increased levels of CO or to vasoconstriction of umbilical artery NOTE: CO=carbon monoxide. Mechanisms for an effect of cigarette smoking on spontaneous abortion have not been clearly defined, partly because so little is known about the pathophysiologic basis for spontaneous abortion. The causes of spontaneous abortion are broadly divided into genetic and nongenetic causes (Kline 1984). Because smoking seems to have its primary impact on chromosomally normal spontaneous abortions (Kline 1984: Alber- man et al. 1976). nongenetic pathways are implicated for smoking (Table |). 372 Most attention has been focused on the mechanisms mediating a reduction of fetal growth among smokers (Table 1). An indirect, nutritionally based mechanism in which smokers are postulated to eat less and gain less weight during pregnancy. thus delivering smaller infants, has been prominent in discussions of fetal growth retardation in smokers (Papoz et al. 1982: Rush 1974; Meyer 1978: Davies and Abernethy 1976). This subject has been reviewed in depth in previous reports of the Surgeon General (US DHEW 1979: US DHHS 1980) and more recently by other researchers (Werler, Pober, Holmes 1985). Differences in weight gain do not entirely explain fetal growth retardation in smokers because differences in weight gain during pregnancy between smokers and nonsmokers are very small and have not been observed consistently and because a relationship between growth retardation and smoking persists after adjusting for mater- nal weight gain. In this context, however, the studies of weight gain in women who quit smoking during pregnancy are of interest. Pulkkinen (1985) found that women who quit smoking during the first trimester gained more weight than nonsmokers or continuing smokers (1.0 vs. 1.3 kg average difference, respectively). Kuzma and Kissinger (1981) also found that women who quit smoking during pregnancy gained more weight compared with women who did not smoke during pregnancy (average difference of 4.7 kg) and women who smoked throughout pregnancy (average difference of 5.6 kg). Also, women who quit smoking before the onset of pregnancy were reported to gain more weight during pregnancy than nonsmokers or smokers (1.3 kg and 0.9 kg average difference, respectively) (Anderson et al. 1984). Rush (1974) reported a reduction in weight gain of 0.12 pounds per week among continuing smokers compared with those who quit. This pattern may reflect the well-established tendency to gain weight following smoking cessation (Manley and Boland 1983: Rabkin 1984), as discussed further in Chapter 11. There are several hypotheses that attempt to explain the mechanism by which fetal growth is affected by cigarette smoking (Table 1), but cigarette smoking is believed to impact on fetal growth through intrauterine hypoxia (Longo 1977). Carbon monoxide, a component of cigarette smoke, has the ability to cross the placenta and bind with the hemoglobin in both the mother and the fetus producing carboxyhemoglobin. Car- boxyhemoglobin reduces the ability of the blood to carry adequate levels of oxygen to the fetus. Smoking is also believed to cause vasoconstriction of the umbilical arteries. and therefore, impact on placental blood flow (Lehtovirta and Forss 1978: Naeye and Tafari 1983; Longo 1982). Cigarette smoking during pregnancy decreases the availability of oxygen to the fetus by both mechanisms. These mechanisms imply a reversible effect of cigarette smoking for fetal growth because normal function would resume shortly after nicotine or CO is cleared from the system. Support for the suggestion that these effects are reversible is derived from several sources. Davies and coworkers (1979) found that 48 hours of smokin g cessation late in pregnancy increased oxygen availability to the fetus. ViSnjevac and Mikov (1986) found similarly low levels of carboxyhemoglobin (COHb) in mothers and newborns when the mother was a former smoker or never smoker: mothers who smoked during pregnancy and their newbors had high levels of COHb. 373 Mechanisms for the effects of smoking on neonatal. perinatal, and infant mortality are poorly understood. although the reduction in birthweight is often considered to be the mediating process. However, smoking appears to cause a shift in the distribution of birthweight without having much effect on mean gestational age (US DHEW 1979, US DHHS 1980), and shifts in birthweight distribution across different populations do not always produce corresponding shifts in mortality (Wilcox 1983; Wilcox and Russell 1983a.b). That gestational age is little affected by smoking, whereas birthweight is reduced at every gestational age. explains why small infants of smokers have a better prognosis than small infants of nonsmokers (Yerushalmy 1971; MacMahon. Alpert, Salber 1966). Increases in perinatal mortality among smokers may result not from the reduction in birthweight, but rather from the modest increases in preterm delivery, very low birthweight, and specific pathologic conditions such as placenta previa and abruptio placentae. However, this has not been addressed explicitly in any study. Because the smaller smoking-related increases in less frequent, more severe outcomes parallel the pronounced smoking-related reduction in birthweight. birthweight serves as a useful empirical marker of smoking’s harmful consequences, even if it is not the direct mediator of those effects. Nonexperimental Studies Fertility and Infertility Consistent evidence indicates that smokers have lower fertility than nonsmokers (Daling et al. 1987: Howe et al. 1985: Baird and Wilcox 1985: Hartz et al. 1987), as noted in the 1989 Report of the Surgeon General (US DHHS 1989). The studies that have assessed indicators of fertility in former smokers are summarized in Table 2. Pettersson. Fries. and Nillius (1973) studied secondary amenorrhea, one mechanism for reduced fertility, and found an increased prevalence among smokers. However, prevalence among former smokers was even higher than among continuing smokers. Hammond (1961) found that irregular menstrual cycles were more common among smokers than never smokers and that former smokers were at slightly lower risk than never smokers. Howe and colleagues (1985) analyzed data on more than 4.000 women in a British cohort study. which assessed the safety of oral contraceptives. Compared with never smokers, women who smoked 20 cigarettes or more at entry into the study were twice as likely to be undelivered 5 years after ceasing contraceptive use with the intention of becoming pregnant. whereas former smokers had the same likelihood of being un- delivered as never smokers. Baird and Wilcox (1985) reported that the time period until pregnancy was the same for 31 women who quit smoking in the year prior to attempting to conceive as it was for never smokers. Daling and coworkers (1987) conducted a large case-control study in Washington State and found that, compared with never smokers, the relative risk of primary tubal infertility was 2.7 among current smokers and 1.1 among former smokers. Information 374 TABLE 2.—Summary of studies of fertility among smokers and former smokers Relative risk of measure of fertility” Measure of Reference Location fertility Smokers Former smokers Pettersson, Fries, Sweden Secondary amenorrhea 13 1.6 Nillius (1973) Howe et al. England Not pregnant S yr after 2.0" 1.0 (1985) ceasing contraceptive use Baird and Wilcox Minnesota Time to pregnancy >I yr 3.4 1.0 (1985) Daling et al. Seattle Primary tubal infertility 2.7 1.0 (1987) Daling et al. Seattle Secondary tubal infertility 1.6 1.3 (1985) “Compared with never smokers. h . Smokers of >20 cig/day . on secondary tubal infertility from the same study (Daling et al. 1985) revealed a smaller difference between current and former smokers. Although the study focused on prior induced abortion, data are presented that allow computation of crude odds ratios for current and former cigarette smokers. Current smokers had a 1.6-fold increase in the risk of secondary tubal infertility, and former smokers had a 1.3-fold increase in risk. It is difficult to assess the causal effect of smoking on tubal infertility independent of the effects of sexually transmitted diseases (STDs) known to co-vary with smoking in many populations. In summary, the data suggest that impairment of fertility measured as delay in time to conception is related to smoking near the time of attempting to conceive and that smoking cessation prior to conception returns fertility to that of never smokers. Conclusions about smoking and the risk of tubal infertility cannot be drawn because of concern about uncontrolled confounding. Ectopic Pregnancy and Spontaneous Abortion Tubal (ectopic) pregnancy occurs at about the same time in the reproductive process as fetal loss. However, the mechanisms are thought to be similar to those operating in tubal infertility and largely concern tubal motility and patency. Several reports indicate an increased risk of ectopic pregnancy in smokers (Campbell and Gray 1987: Mat- sunaga and Shiota 1980), but only Chow and associates (1988) examined the associa- tion with prior smoking in detail. In a case-control study in western Washington State. 155 cases of tubal pregnancy were compared with 456 controls who had given birth. Current smokers had an estimated 2.2-fold increased risk of ectopic pregnancy com- 375